BR0211533A - Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas - Google Patents
Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminasInfo
- Publication number
- BR0211533A BR0211533A BR0211533-6A BR0211533A BR0211533A BR 0211533 A BR0211533 A BR 0211533A BR 0211533 A BR0211533 A BR 0211533A BR 0211533 A BR0211533 A BR 0211533A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- chronic pain
- aryloxypropanamines
- heterocyclyl
- cycloalkyl
- Prior art date
Links
- 208000000094 Chronic Pain Diseases 0.000 title abstract 3
- 208000002193 Pain Diseases 0.000 title abstract 3
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30908401P | 2001-07-31 | 2001-07-31 | |
| PCT/US2002/021301 WO2003011289A1 (en) | 2001-07-31 | 2002-07-29 | Treatment of chronic pain with 3-heterocyclyl- and 3-cycloalkyl-3-aryloxypropanamines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0211533A true BR0211533A (pt) | 2004-07-13 |
Family
ID=23196615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0211533-6A BR0211533A (pt) | 2001-07-31 | 2002-07-29 | Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030087938A1 (https=) |
| EP (1) | EP1411934A1 (https=) |
| JP (1) | JP2004538305A (https=) |
| BR (1) | BR0211533A (https=) |
| CA (1) | CA2451288A1 (https=) |
| MX (1) | MXPA04000418A (https=) |
| WO (1) | WO2003011289A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2007006777A (es) * | 2004-12-06 | 2007-08-06 | Avigen Inc | Ibudilast para tratar dolor neuropatico y sindromes asociados. |
| GB0523550D0 (en) | 2005-11-18 | 2005-12-28 | Hunter Fleming Ltd | Therapeutic uses of steroidal compounds |
| US20080181876A1 (en) * | 2007-01-30 | 2008-07-31 | Johnson Kirk W | Methods for treating acute and subchronic pain |
| WO2008137012A1 (en) * | 2007-05-03 | 2008-11-13 | Avigen, Inc. | Use of a glial attenuator to prevent amplified pain responses caused by glial priming |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4035511A (en) * | 1976-05-06 | 1977-07-12 | Massachusetts Institute Of Technology | Process for promoting analgesia |
| US4596807A (en) * | 1985-03-26 | 1986-06-24 | Serotonin Industries Of Charleston | Method and compositions for controlling pain, depression and sedation |
| US4956388A (en) * | 1986-12-22 | 1990-09-11 | Eli Lilly And Company | 3-aryloxy-3-substituted propanamines |
| US5250572A (en) * | 1990-03-29 | 1993-10-05 | Eli Lilly And Company | (R)-norfluoxetine in method for occupying serotonin IC receptors |
| US5589511A (en) * | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
| US5104899A (en) * | 1990-08-13 | 1992-04-14 | Sepracor, Inc. | Methods and compositions for treating depression using optically pure fluoxetine |
| ZA958725B (en) * | 1994-10-20 | 1997-04-16 | Lilly Co Eli | Treatment of disorders with duloxetine |
| US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
| DK1113797T3 (da) * | 1998-09-15 | 2010-02-01 | Lilly Co Eli | Anvendelse af duloxetin til behandling af fibromyalgi |
| GB0004153D0 (en) * | 2000-02-23 | 2000-04-12 | Astrazeneca Uk Ltd | Novel use |
-
2002
- 2002-07-29 JP JP2003516519A patent/JP2004538305A/ja not_active Withdrawn
- 2002-07-29 MX MXPA04000418A patent/MXPA04000418A/es not_active Application Discontinuation
- 2002-07-29 US US10/207,511 patent/US20030087938A1/en not_active Abandoned
- 2002-07-29 WO PCT/US2002/021301 patent/WO2003011289A1/en not_active Ceased
- 2002-07-29 BR BR0211533-6A patent/BR0211533A/pt not_active Application Discontinuation
- 2002-07-29 EP EP02748080A patent/EP1411934A1/en not_active Withdrawn
- 2002-07-29 CA CA002451288A patent/CA2451288A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004538305A (ja) | 2004-12-24 |
| MXPA04000418A (es) | 2004-03-18 |
| WO2003011289A1 (en) | 2003-02-13 |
| US20030087938A1 (en) | 2003-05-08 |
| CA2451288A1 (en) | 2003-02-13 |
| EP1411934A1 (en) | 2004-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60109589D1 (de) | Pharmazeutische zusammensetzung zur behandlung von akutem schmerz, chronischem schmerz und/oder neuropathischem schmerz und migräne | |
| EE200300485A (et) | Tiohüdantoinid ja nende kasutamine diabeedi raviks | |
| DE69905170T2 (de) | Thiazolopyrimidinderivate | |
| BR0009480A (pt) | Soluções de poliuretano com unidades de estrutura de alcoxissilano | |
| CL2004001174A1 (es) | Composicion farmaceutica que comprende: 1-(4-fluorofenil)-3(r)-[3-(4-fluorofenil)-3(s)-hidroxipropil]-4(s)-(4-hidroxifenil)-2-acetidinona (ezetimiba) y excipientes; y su uso en el tratamiento y/o prevencion de aterosclerosis, hipercolesterolemia, dia | |
| DE60121988D1 (de) | Kombinationstherapie mit antidiabetischen und antikonvulsiven mitteln | |
| CO5611160A2 (es) | Conjugados de agentes terapeuticos o citotoxicos y peptidos biologicamente activos | |
| SG152279A1 (en) | Interfering rna duplex having blunt-ends and 3æ-modifications | |
| EP2335722A3 (en) | Use of gelsolin to treat infections | |
| CY1109361T1 (el) | Υποκατεστημενες 4-αμινοκυκλοεξανολες | |
| ATE346614T1 (de) | Vaginale zusammensetzung enthaltend lidocaine zur behandlung von gebärmutterrhythmusstörung | |
| ATE355104T1 (de) | Haarbehandlungsmittel | |
| SE9904377D0 (sv) | Pharmaceutical combinations | |
| BR0114912A (pt) | Kahalalide f | |
| ATE256461T1 (de) | Benutzung von comt-inhibitoren als analgetika | |
| EE200300213A (et) | SARP-1 kasutamine sklerodermia raviks ja/või ennetamiseks | |
| BR0211533A (pt) | Tratamento de dor crÈnica com 3-heterociclil- e 3-cicloalquil-3-ariloxipropanaminas | |
| EA200000909A1 (ru) | ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА | |
| BR0214060A (pt) | Uso de monoidroxicarbamazepina em distúrbio afetivo e de atenção e dor neuropática | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| BR0211522A (pt) | Tratamento de dor crÈnica com 3-arilóxi-3-fenilpropanaminas | |
| TR200002939T2 (tr) | Paroksetin maleat | |
| BR0002640A (pt) | Uso de simeticona para tratar colite ulcerativa | |
| DK1052991T3 (da) | Topisk anvendelse af loperamid til behandling af mikrobielle infektioner | |
| FI20012016L (fi) | Eettereitä hajottavia bakteereita ja niiden käyttö |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |